Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

STI clinical trials

2 of 6 indexed STI trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

STI: 6 US clinical trials tracked, 2 recruiting.

STI is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is University of Connecticut, running 1 of these trials.

Enrollment posture brief

Registry condition sti

OPEN 2 | RECR 33% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%STI (this)33%
Open-enrollment share among volume-matched conditions near STI

STI lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for STI on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. STI is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates STI research.

    University of Connecticut accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical STI enrolment sits around 458 participants.

    Median target enrolment is 458 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. STI research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on STI records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

General Health Control Intervention Behavioral
1 trials
HIV/STI Prevention Intervention Behavioral
1 trials
STIckER Behavioral
1 trials
HIV/STI testing Behavioral
1 trials
Motivational interview Behavioral
1 trials
Combine mobile app Behavioral
1 trials
Stigma counseling for PrEP use Behavioral
1 trials
Peer Navigation Behavioral
1 trials

US sites by state

Facility locations filed on STI trials. A trial with sites in several states counts in each.

Georgia 2 trials
Washington 1 trials
Pennsylvania 1 trials
New York 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this STI page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This STI condition card totals 6 registered trials; most-linked intervention General Health Control Intervention; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.